title: CASE 1. Complete remission to corticosteroids in an octreotide-refractory thymoma.
authors.affiliation: Natioal Institute for Cancer Research, Genova, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Tiseo
authors.forename: F
authors.initials: F
authors.lastname: Monetti
authors.forename: M
authors.initials: M
authors.lastname: Ferrarini
authors.forename: J
authors.initials: J
authors.lastname: Serrano
authors.forename: M
authors.initials: M
authors.lastname: Chiaramondia
authors.forename: A
authors.initials: A
authors.lastname: Ardizzoni
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D011241:Prednisone / Q000008:administration & dosage*; D012074:Remission Induction; D013945:Thymoma / Q000188:drug therapy*; D013953:Thymus Neoplasms / Q000188:drug therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide; D011241:Prednisone